Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats

Journal of Trace Elements in Medicine and Biology

Volumn 20, Issue 1, 2006, Pages 33-39

  Machaliński, Bogusław ^a   Walczak, Mieczysław ^a   Syrenicz, Anhelli ^a   Machalińska, Anna ^a   Grymuła, Katarzyna ^a   Stecewicz, Iwona ^a   Wiszniewska, Barbara ^a   Dabkowska, Elzbieta ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Chromium 454; Chromium picolinate; Hyperglycemia; Rats; Streptozocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHROMIUM 454; CHROMIUM DERIVATIVE; CHROMIUM PICOLINATE; CREATINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG POTENCY; DRUG SOLUBILITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WEIGHT GAIN;

ANIMALIA;

EID: 33646037640     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2006.01.002     Document Type: Article

References (32)

1. Schwarz K., and Mertz W. A glucose tolerance factor and its differentiation form factor 3. Arch Biochem Biophys 72 (1957) 515-518
2. Schwarz K., and Mertz W. Chromium (III) and the glucose tolerance factor. Arch Biochem Biophys 85 (1959) 292-295
3. Morris B.W. Chromium action and glucose homeostasis. J Trace Elem Exp Med 12 (1999) 61-70
4. Lamson D.W., and Plaza S.M. The safety and efficacy of high-dose chromium. Alternative Med Rev 7 (2002) 218-235
5. Vincent J.B. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev 3 (2000) 67-73
6. Brown M. Harnessing chromium in the fight against diabetes. Drug Discov Today 8 (2003) 962-963
7. Cong L.N., Chen H., Li Y., Zhou L., McGibbon M.A., Taylor S.I., et al. Physiological role of AKT in insulin-stimulated translocation of Glut4 in transfected rat adipose tissue. Mol Endocrinol 11 (1997) 1881-1890
8. Goldstein B.J., Zhu L., Hager R., Zilbering A., Sun Y., and Vincent J.B. Enhancement of post-receptor insulin signaling by trivalent chromium in hepatoma cells is associated with differential inhibition of specific protein-tyrosine phosphatase. J Trace Elem Exp Med 14 (2001) 393-404
9. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20 (2000) 547-589
10. Like A.A., and Rossini A.A. Streptozocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193 (1976) 415-417
11. Wakame D.K. Protective effects of active hexose correlated compound (AHCC) on the onset of diabetes induced by streptozocin in the rat. Biomed Res 20 (1999) 145-152
12. Rumble J.R., Cooper M.E., Soulis T., Cox A., Wu L., Youseef S., et al. Vascular hypertrophy in experimental diabetes. J Clin Invest 99 (1997) 1016-1027
13. Wallberg-Harrison H., and Holoszy J.O. Activation of glucose transport in diabetic muscle: response to contraction and insulin. Am J Physiol 249 (1985) 233-237
14. Goodyear L.J., Hirshman M.F., Knutson S., Horton E.D., and Horton E.S. Effect of exercise training on glucose homeostasis in normal and insulin-deficient diabetic rats. J Appl Physiol 65 (1988) 844-851
15. Markun J.F., Napoli R., Hirshman M.F., Davalli A.M., Cheatham B., and Goodyear L.J. Effect of streptozocin-induced diabetes and ilst cell transplantation on insulin signaling in rat skeletal muscle. Endocrinology 140 (1999) 106-111
16. Yamada K., Nakata M., Horimoto N., Saito M., Matsuoka H., and Inagaki N. Measurement of glucose and intracellular cacium concentration in single, living pancreatic beta-cells. J Biol Chem 275 (2000) 22278-22283
17. Vannucci S.J., Maher F., Koehler E., and Simpson I.A. Altered expression of Glut-1 and Glut-3 glucose transporters in neurohypophysis of water-deprived or diabetic rats. Am J Physiol 267 (1994) 605-611
18. Ahloulay M., Schmitt F., Dechaux M., and Bankir L. Vasopressin and urinary concentration activity in diabetes mellitus. Diabetes Metab 25 (1999) 213-228
19. Tominaga M., Kimura M., Sugiyama K., Abe T., Igarashi K., Eguchi M., et al. Effects of seishin-renshi-in and Gymnenma sylvestre on insulin resistance in streptozocin-induced diabetic rats. Diabetes Res Clin Pract 29 (1995) 11-17
20. Napoli R., Davalli A.M., Hirshman M.F., Weitgasser R., Weir G.C., and Horton E.S. Islet transplantaion under the kidney capsule fully corrects the impaired skeletal muscle glucose transport system of streptozocin diabetic rats. J Clin Invest 97 (1996) 1389-1397
21. Davalli A.M., Napoli R., Weitgasser R., Capotorto J.V., Hirshman M.F., Finegood D.T., et al. Long-term normalization of Glut4 protein content in skeletal muscle of diabetic rats following islet transplantation. J Endorcinol 150 (1996) 255-263
22. Papaccio G., Latronico M., and Baccari G.C. The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets by low dose streptozocin. Cell Tissue Res 277 (1994) 573-578
23. Brozonick J.T., Roberts Jr. B.R., and Dohm G.L. Defective signaling through AKT-2 and-3 but not AKT-1 in insulin-resistant human skeletal muscle. Diabetes 52 (2003) 935-941
24. Zhang X.F., and Tan B.K. Antihyperglycemic and anti-oxidant properties of andrographis paniculata in normal and diabetic rats. Clin Exp Phram Physiol 27 (2000) 358-363
25. Sun Y., Clodfelder B.J., Ahute A.A., Irvin T., and Vincent J.B. The biometic Cr3+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J Biol Inorg Chem 7 (2002) 852-862
26. Kim D.S., Kim T.W., and Kang J.S. Chromium pollinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J Trace Elem Med Biol 17 (2004) 243-247
27. Davis M.L., Seaborn C.D., and Stoecker B.J. Effects of over-the -counter drugs on chromium retention and urinary excretion in rats. Nutr Res 15 (1995) 202-210
28. Seaborn C.D., and Stoecker B.J. Effect of antacid or ascorbic acid on tissue accumulation and urinary excretion of chromium. Nutr Res 10 (1990) 1401-1407
29. Althuis M.D., Jordan N.E., Ludington E.A., and Wittes J.T. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 76 (2002) 148-155
30. Storr J., Mitchel D., Buglyo P., Thompson K.H., Yuen V.G., McNeill J.H., et al. Vanadyl-thiazolidinedione combination agents for diabetes therapy. Bioconjugate Chem 14 (2003) 212-221
31. McNeill J.H., Delgatty H.L., and Battell M.L. Inulinlike effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 40 (1992) 1675-1678
32. Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414 (2001) 821-827